{"entity":{"type":"insider","cik":"0001256708","url":"/insider/0001256708","json_url":"/insider/0001256708.json","name":"SHERMAN MARK ANDREW","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":94,"n_filings":52,"first":"2012-02-08","last":"2025-12-17","span_basis":"filed_date"},"name_variants":[{"name":"SHERMAN MARK ANDREW","source":"filing","n_filings":52,"first_seen":"2012-02-08","last_seen":"2025-12-17"}],"transactions":[{"id":4045160,"accession":"0001193125-25-323425","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-323425","line_url":"/filing/0001193125-25-323425#line-7","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2491.0,"shares_display":"2,491","price_per_share":67.2637,"price_display":"67.26","price_state":"stated","total_value":167553.8767,"total_display":"167,553.88","total_whole":"167,554","shares_owned_after":70563.0,"shares_owned_after_display":"70,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-17","scope":"insider"},{"id":4045159,"accession":"0001193125-25-323425","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-323425","line_url":"/filing/0001193125-25-323425","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9109.0,"shares_display":"9,109","price_per_share":66.73059566362937,"price_display":"66.73","price_state":"stated","total_value":607848.9959,"total_display":"607,849.00","total_whole":"607,849","shares_owned_after":75425.0,"shares_owned_after_display":"75,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-17","scope":"insider","n_lines":2},{"id":4578811,"accession":"0001193125-25-307131","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-307131","line_url":"/filing/0001193125-25-307131#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":67.5635,"price_display":"67.56","price_state":"stated","total_value":304035.75,"total_display":"304,035.75","total_whole":"304,036","shares_owned_after":62397.0,"shares_owned_after_display":"62,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":5033664,"accession":"0000950170-25-083386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-083386","line_url":"/filing/0000950170-25-083386#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":75.0191,"price_display":"75.02","price_state":"stated","total_value":1125286.5,"total_display":"1,125,286.50","total_whole":"1,125,287","shares_owned_after":62397.0,"shares_owned_after_display":"62,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider"},{"id":4946706,"accession":"0000950170-25-081036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-081036","line_url":"/filing/0000950170-25-081036#line-1","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":74.97,"price_display":"74.97","price_state":"stated","total_value":26239.5,"total_display":"26,239.50","total_whole":"26,240","shares_owned_after":62397.0,"shares_owned_after_display":"62,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-30","filed_date":"2025-06-03","scope":"insider"},{"id":4455141,"accession":"0000950170-25-012643","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-012643","line_url":"/filing/0000950170-25-012643","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":84.8775625,"price_display":"84.88","price_state":"stated","total_value":3395102.5,"total_display":"3,395,102.50","total_whole":"3,395,103","shares_owned_after":62397.0,"shares_owned_after_display":"62,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-02-03","scope":"insider","n_lines":2},{"id":2243577,"accession":"0000950170-24-138158","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-138158","line_url":"/filing/0000950170-24-138158","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12338.0,"shares_display":"12,338","price_per_share":78.0761422353704,"price_display":"78.08","price_state":"stated","total_value":963303.4429,"total_display":"963,303.44","total_whole":"963,303","shares_owned_after":62397.0,"shares_owned_after_display":"62,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider","n_lines":2},{"id":2177100,"accession":"0000950170-24-066668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-066668","line_url":"/filing/0000950170-24-066668#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2283.0,"shares_display":"2,283","price_per_share":79.62,"price_display":"79.62","price_state":"stated","total_value":181772.46,"total_display":"181,772.46","total_whole":"181,772","shares_owned_after":58325.0,"shares_owned_after_display":"58,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":8156731,"accession":"0001209191-23-059261","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-059261","line_url":"/filing/0001209191-23-059261#line-6","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663.0,"shares_display":"1,663","price_per_share":86.0122,"price_display":"86.01","price_state":"stated","total_value":143038.2886,"total_display":"143,038.29","total_whole":"143,038","shares_owned_after":58325.0,"shares_owned_after_display":"58,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-19","scope":"insider"},{"id":8156728,"accession":"0001209191-23-059261","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-059261","line_url":"/filing/0001209191-23-059261#line-5","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8856.0,"shares_display":"8,856","price_per_share":86.1868,"price_display":"86.19","price_state":"stated","total_value":763270.3008,"total_display":"763,270.30","total_whole":"763,270","shares_owned_after":59988.0,"shares_owned_after_display":"59,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-19","scope":"insider"},{"id":8254485,"accession":"0001209191-23-042270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042270","line_url":"/filing/0001209191-23-042270#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":89.0,"price_display":"89.00","price_state":"stated","total_value":1869000.0,"total_display":"1,869,000.00","total_whole":"1,869,000","shares_owned_after":56730.0,"shares_owned_after_display":"56,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-14","scope":"insider"},{"id":7998085,"accession":"0001209191-23-028505","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-028505","line_url":"/filing/0001209191-23-028505","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":83.5942688,"price_display":"83.59","price_state":"stated","total_value":1253914.032,"total_display":"1,253,914.03","total_whole":"1,253,914","shares_owned_after":58554.0,"shares_owned_after_display":"58,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-10","scope":"insider","n_lines":2},{"id":8363320,"accession":"0001209191-23-007699","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-007699","line_url":"/filing/0001209191-23-007699#line-3","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2413.0,"shares_display":"2,413","price_per_share":83.6454,"price_display":"83.65","price_state":"stated","total_value":201836.3502,"total_display":"201,836.35","total_whole":"201,836","shares_owned_after":56374.0,"shares_owned_after_display":"56,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-07","scope":"insider"},{"id":8363316,"accession":"0001209191-23-007699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-007699","line_url":"/filing/0001209191-23-007699#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Counsel & Secretary","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":1020000.0,"total_display":"1,020,000.00","total_whole":"1,020,000","shares_owned_after":58787.0,"shares_owned_after_display":"58,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-07","scope":"insider"},{"id":6253914,"accession":"0001209191-22-062429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062429","line_url":"/filing/0001209191-22-062429#line-1","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1638.0,"shares_display":"1,638","price_per_share":68.09,"price_display":"68.09","price_state":"stated","total_value":111531.42,"total_display":"111,531.42","total_whole":"111,531","shares_owned_after":58787.0,"shares_owned_after_display":"58,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-22","scope":"insider"},{"id":6788956,"accession":"0001209191-22-062075","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-062075","line_url":"/filing/0001209191-22-062075","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5070.0,"shares_display":"5,070","price_per_share":69.84413368836292,"price_display":"69.84","price_state":"stated","total_value":354109.7578,"total_display":"354,109.76","total_whole":"354,110","shares_owned_after":60757.0,"shares_owned_after_display":"60,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-19","scope":"insider","n_lines":2},{"id":6788939,"accession":"0001209191-22-062075","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-062075","line_url":"/filing/0001209191-22-062075#line-5","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2334.0,"shares_display":"2,334","price_per_share":70.6604,"price_display":"70.66","price_state":"stated","total_value":164921.3736,"total_display":"164,921.37","total_whole":"164,921","shares_owned_after":67107.0,"shares_owned_after_display":"67,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider"},{"id":6388334,"accession":"0001209191-22-008259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008259","line_url":"/filing/0001209191-22-008259#line-1","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1798.0,"shares_display":"1,798","price_per_share":77.23,"price_display":"77.23","price_state":"stated","total_value":138859.54,"total_display":"138,859.54","total_whole":"138,860","shares_owned_after":51601.0,"shares_owned_after_display":"51,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-09","scope":"insider"},{"id":4679591,"accession":"0001209191-21-070706","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-070706","line_url":"/filing/0001209191-21-070706#line-3","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1638.0,"shares_display":"1,638","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":148550.22,"total_display":"148,550.22","total_whole":"148,550","shares_owned_after":53399.0,"shares_owned_after_display":"53,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-20","scope":"insider"},{"id":4679586,"accession":"0001209191-21-070706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-070706","line_url":"/filing/0001209191-21-070706#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663.0,"shares_display":"1,663","price_per_share":90.17,"price_display":"90.17","price_state":"stated","total_value":149952.71,"total_display":"149,952.71","total_whole":"149,953","shares_owned_after":55037.0,"shares_owned_after_display":"55,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-20","scope":"insider"},{"id":4774712,"accession":"0001209191-21-016831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-016831","line_url":"/filing/0001209191-21-016831#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1300000.0,"total_display":"1,300,000.00","total_whole":"1,300,000","shares_owned_after":50010.0,"shares_owned_after_display":"50,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5190746,"accession":"0001209191-21-011290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011290","line_url":"/filing/0001209191-21-011290#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":1235000.0,"total_display":"1,235,000.00","total_whole":"1,235,000","shares_owned_after":50010.0,"shares_owned_after_display":"50,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":4258512,"accession":"0001209191-21-008662","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-008662","line_url":"/filing/0001209191-21-008662","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27663.0,"shares_display":"27,663","price_per_share":91.596168137946,"price_display":"91.60","price_state":"stated","total_value":2533824.7992,"total_display":"2,533,824.80","total_whole":"2,533,825","shares_owned_after":50506.0,"shares_owned_after_display":"50,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-08","scope":"insider","n_lines":6},{"id":2660183,"accession":"0001209191-20-064695","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-064695","line_url":"/filing/0001209191-20-064695#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1638.0,"shares_display":"1,638","price_per_share":91.9594,"price_display":"91.96","price_state":"stated","total_value":150629.4972,"total_display":"150,629.50","total_whole":"150,629","shares_owned_after":51673.0,"shares_owned_after_display":"51,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-21","scope":"insider"},{"id":4437372,"accession":"0001209191-21-070104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-070104","line_url":"/filing/0001209191-21-070104","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1764.0,"shares_display":"1,764","price_per_share":91.14215736961451,"price_display":"91.14","price_state":"stated","total_value":160774.7656,"total_display":"160,774.77","total_whole":"160,775","shares_owned_after":58644.0,"shares_owned_after_display":"58,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2021-12-16","scope":"insider","n_lines":2},{"id":3209854,"accession":"0001209191-20-064236","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-064236","line_url":"/filing/0001209191-20-064236","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3402.0,"shares_display":"3,402","price_per_share":90.72206513815402,"price_display":"90.72","price_state":"stated","total_value":308636.4656,"total_display":"308,636.47","total_whole":"308,636","shares_owned_after":55260.0,"shares_owned_after_display":"55,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider","n_lines":2},{"id":2192557,"accession":"0001209191-20-057140","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-057140","line_url":"/filing/0001209191-20-057140","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":80.000869608,"price_display":"80.00","price_state":"stated","total_value":2000021.7402,"total_display":"2,000,021.74","total_whole":"2,000,022","shares_owned_after":49038.0,"shares_owned_after_display":"49,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-05","scope":"insider","n_lines":2},{"id":2975937,"accession":"0001209191-20-056637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-056637","line_url":"/filing/0001209191-20-056637#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":76.0003,"price_display":"76.00","price_state":"stated","total_value":1900007.5,"total_display":"1,900,007.50","total_whole":"1,900,008","shares_owned_after":49038.0,"shares_owned_after_display":"49,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":2074894,"accession":"0001209191-20-011099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-011099","line_url":"/filing/0001209191-20-011099#line-2","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":1460000.0,"total_display":"1,460,000.00","total_whole":"1,460,000","shares_owned_after":48651.0,"shares_owned_after_display":"48,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-20","scope":"insider"},{"id":2679062,"accession":"0001209191-20-008135","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-008135","line_url":"/filing/0001209191-20-008135","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36615.0,"shares_display":"36,615","price_per_share":71.99879036733579,"price_display":"72.00","price_state":"stated","total_value":2636235.7093,"total_display":"2,636,235.71","total_whole":"2,636,236","shares_owned_after":48651.0,"shares_owned_after_display":"48,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-10","scope":"insider","n_lines":2},{"id":2625192,"accession":"0001209191-20-007343","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-007343","line_url":"/filing/0001209191-20-007343","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":71.95644878,"price_display":"71.96","price_state":"stated","total_value":3597822.439,"total_display":"3,597,822.44","total_whole":"3,597,822","shares_owned_after":48651.0,"shares_owned_after_display":"48,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-06","scope":"insider","n_lines":3},{"id":8492863,"accession":"0001209191-19-044359","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-044359","line_url":"/filing/0001209191-19-044359","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":67.73,"price_display":"67.73","price_state":"stated","total_value":507975.0,"total_display":"507,975.00","total_whole":"507,975","shares_owned_after":48576.0,"shares_owned_after_display":"48,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-02","scope":"insider","n_lines":2},{"id":8492848,"accession":"0001209191-19-044359","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-044359","line_url":"/filing/0001209191-19-044359#line-4","is_derivative":false,"issuer_cik":"0001256708","issuer_name":"Dolby Laboratories, Inc.","issuer_ticker":"DLB","issuer_name_source":null,"issuer_url":"/issuer/0001256708","owner_cik":"0001256708","owner_name":"SHERMAN MARK ANDREW","owner_display_name":"SHERMAN MARK ANDREW","owner_url":"/insider/0001256708","role":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark":"O","role_mark_label":"Officer (EVP, GEN. COUN. & SECRTY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GEN. COUN. & SECRTY","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29790.0,"shares_display":"29,790","price_per_share":67.5,"price_display":"67.50","price_state":"stated","total_value":2010825.0,"total_display":"2,010,825.00","total_whole":"2,010,825","shares_owned_after":48576.0,"shares_owned_after_display":"48,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-08-02","scope":"insider"}],"collapsed":true,"next_cursor":"2019-07-31|8492848","ledger_fault":false,"count":{"value":94,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":94,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":94},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001308547","name":"Dolby Laboratories, Inc.","url":"/issuer/0001308547","role":"Officer (EVP, Gen. Counsel & Secretary)","n_filings":52,"first_seen":"2012-02-08","last_seen":"2025-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001256708","retrieved_at":"2026-08-22T16:24:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}